Çevik, U. A. Et Al. 2025. Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS Omega , vol.10, no.7 , 6801-6813.

Çevik, U. A., ÇELİK, İ., Görgülü, Ş., ŞAHİN İNAN, Z. D., BOSTANCI, H. E., Karayel, A., ... ÖZKAY, Y.(2025). Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS Omega , vol.10, no.7, 6801-6813.

Çevik, Ulviye Et Al. "Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies," ACS Omega , vol.10, no.7, 6801-6813, 2025

Çevik, Ulviye A. Et Al. "Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies." ACS Omega , vol.10, no.7, pp.6801-6813, 2025

Çevik, U. A. Et Al. (2025) . "Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies." ACS Omega , vol.10, no.7, pp.6801-6813.

@article{article, author={Ulviye Acar Çevik Et Al. }, title={Novel Benzimidazole-Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies}, journal={ACS Omega}, year=2025, pages={6801-6813} }